ZA8892B - Dopamine-beta-hydroxylase inhibitors - Google Patents
Dopamine-beta-hydroxylase inhibitorsInfo
- Publication number
- ZA8892B ZA8892B ZA8892A ZA8892A ZA8892B ZA 8892 B ZA8892 B ZA 8892B ZA 8892 A ZA8892 A ZA 8892A ZA 8892 A ZA8892 A ZA 8892A ZA 8892 B ZA8892 B ZA 8892B
- Authority
- ZA
- South Africa
- Prior art keywords
- dopamine
- beta
- hydroxylase inhibitors
- hydroxylase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/001,282 US4749717A (en) | 1987-01-08 | 1987-01-08 | Dopamine-beta-hydroxylase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA8892B true ZA8892B (en) | 1988-11-30 |
Family
ID=21695240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA8892A ZA8892B (en) | 1987-01-08 | 1988-01-07 | Dopamine-beta-hydroxylase inhibitors |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4749717A (da) |
| EP (1) | EP0274434A1 (da) |
| JP (1) | JPS63174985A (da) |
| AU (1) | AU1003188A (da) |
| DK (1) | DK2488A (da) |
| PT (1) | PT86513B (da) |
| ZA (1) | ZA8892B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189052A (en) * | 1986-05-06 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Thione dopamine beta hydroxylase inhibitors |
| US5057613A (en) * | 1986-05-06 | 1991-10-15 | Merrell Dow Pharmaceuticals | Novel thione dopamine beta hydroxylase inhibitors |
| US6545163B1 (en) * | 1995-10-02 | 2003-04-08 | Napp Technologies | Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers |
| US20050070499A1 (en) * | 1999-11-08 | 2005-03-31 | Pfizer Inc. | Compounds for the treatment of female sexual dysfunction |
| IL139457A0 (en) | 1999-11-08 | 2001-11-25 | Pfizer | Compounds for the treatment of female sexual dysfunction |
| EP3971178A1 (en) | 2012-03-07 | 2022-03-23 | The McLean Hospital Corporation | Aminoquinoline derivatives and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2278683A1 (fr) * | 1974-07-16 | 1976-02-13 | Parcor | Procede de preparation de la thieno(3,2-c)pyridine et de la thieno(2,3-c)pyridine |
| JPS604181A (ja) * | 1983-06-22 | 1985-01-10 | Tokuyama Soda Co Ltd | Ｎ−置換−クロロアセトアニリド |
| US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
-
1987
- 1987-01-08 US US07/001,282 patent/US4749717A/en not_active Expired - Fee Related
-
1988
- 1988-01-04 AU AU10031/88A patent/AU1003188A/en not_active Abandoned
- 1988-01-05 DK DK002488A patent/DK2488A/da unknown
- 1988-01-07 ZA ZA8892A patent/ZA8892B/xx unknown
- 1988-01-07 JP JP63001800A patent/JPS63174985A/ja active Pending
- 1988-01-07 EP EP88300100A patent/EP0274434A1/en not_active Withdrawn
- 1988-01-08 PT PT86513A patent/PT86513B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0274434A1 (en) | 1988-07-13 |
| US4749717A (en) | 1988-06-07 |
| PT86513B (pt) | 1992-02-28 |
| AU1003188A (en) | 1988-07-14 |
| JPS63174985A (ja) | 1988-07-19 |
| PT86513A (en) | 1988-02-01 |
| DK2488D0 (da) | 1988-01-05 |
| DK2488A (da) | 1988-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT78388A (en) | Dopamine-beta-hydroxylase inhibitors | |
| EP0289506A4 (en) | Lipoxygenase inhibitors | |
| ZA884838B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA883851B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83076B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT85081A (en) | Irreversible dopamine-beta-hydroxylase inhibitors | |
| PT83628A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA889709B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA889667B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA873653B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT86513A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA882100B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT85596B (en) | Dopamine-beta-hydroxylase inhibitors | |
| AU2911389A (en) | 1-aralkyl-2-mercaptoimidazolines as dopamine-beta-hydroxylase inhibitors | |
| PT83626B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA86949B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA882275B (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE880860L (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE882030L (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE872276L (en) | DOPAMINE-ß-HYDROXYLASE INHIBITORS | |
| ZA842963B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA842962B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZW4285A1 (en) | Dopamine-beta-hydroxylase inhibitors | |
| GB8810810D0 (en) | New use | |
| DE3477926D1 (en) | Dopamine-beta-hydroxylase inhibitors |